About Quintus Life Sciences Private Limited
Data last updated:
Quintus Life Sciences Private Limited is a private limited company based in Jambhulpada, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74994MH2016PTC280667. Its GSTIN is 27AAACQ4234B1ZW (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Raghavendra Manikrao Agade and Sudesh Panjabrao Rewaskar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Siddharth C – 101, Jambhulpada, Maharashtra, India – 410205.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.32 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹8.19 Lakh (net margin 1.9%) and EBITDA of ₹17.14 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website quintuslifesciences.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressSiddharth C – 101, Jambhulpada, Maharashtra, India – 410205
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Quintus Life Sciences Private Limited
The main business activity of Quintus Life Sciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Quintus Life Sciences Private Limited FY 2025 filings available
Quintus Life Sciences Private Limited reported revenue of ₹4.32 Cr (up 20% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Quintus Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 20% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Quintus Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹17.14 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Quintus Life Sciences Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Quintus Life Sciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Quintus Life Sciences Private Limited
Quintus Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biofusion Alliance Private Limited | ₹4.34 Cr (FY 2025) | •••• | •••• | 34.0% | •••• | Lucknow, Uttar Pradesh, India |
| The Doson Chemicals Private Limited | ₹4.34 Cr (FY 2025) | •••• | •••• | -4.0% | •••• | Guwahati, Assam, India |
| Stan Rel Private Limited | ₹4.33 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Vadodara, Gujarat, India |
| Mecoson Labs Private Limited | ₹4.33 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Surat, Gujarat, India |
| Alpic Remedies Limited | ₹4.32 Cr (FY 2023) | •••• | •••• | 3.0% | •••• | Ahmedabad, Gujarat, India |
| Quintus Life Sciences Private Limited this company | ₹4.32 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Jambhulpada, Maharashtra, India |
| Zantic Pharmaceuticals Private Limited | ₹4.32 Cr (FY 2024) | •••• | •••• | 58.0% | •••• | Vikasnagar, Uttarakhand, India |
| Paulvia Traders Private Limited | ₹4.31 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Kolkata, West Bengal, India |
| Pharma-Tone Private Limited | ₹4.31 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Wings Biotech Limited | ₹4.31 Cr (FY 2019) | •••• | •••• | -14.0% | •••• | Delhi, India |
| M. R. Laboratories Private Limited | ₹4.3 Cr (FY 2025) | •••• | •••• | -2.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Quintus Life Sciences by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Quintus Life Sciences Private Limited
Quintus Life Sciences Private Limited is audited by GHATE DESHPANDE & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GHATE DESHPANDE & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Quintus Life Sciences Private Limited
Quintus Life Sciences has 5 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghavendra Manikrao Agade | Director | 03 May 2016 | 10 Years 5 Months | Current |
| Sudesh Panjabrao Rewaskar | Director | 03 May 2016 | 10 Years 5 Months | Current |
| Sunil Marotrao Ghumde | Director | 03 May 2016 | 10 Years 5 Months | Current |
| Sandip Dinakarrao Bavane | Director | 03 May 2016 | 10 Years 5 Months | Current |
| Sachin Korekar | Director | 03 May 2016 | 10 Years 5 Months | Current |
Ownership and Shareholding of Quintus Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Quintus Life Sciences Private Limited
Quintus Life Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Quintus Life Sciences Private Limited
Employment history and EPFO contributions of people linked to Quintus Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Quintus Life Sciences Private Limited
Quintus Life Sciences Private Limited has 5 board changes on record since 2016: 5 appointments. The latest: Raghavendra Manikrao Agade was appointed as Director on 03 May 2016.
Credit Ratings, Litigation & Regulatory Alerts for Quintus Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Quintus Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Quintus Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Quintus Life Sciences Private Limited
Quintus Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACQ4234B1ZW | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Quintus Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quintus Life Sciences Private Limited
Quintus Life Sciences is an active private limited company based in Jambhulpada, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 May 2016 (10+ years old) and is registered under CIN U74994MH2016PTC280667.
Quintus Life Sciences reported revenue of ₹4.32 Cr for FY 2024 (up 20% YoY).
Quintus Life Sciences has 5 current directors:
- Raghavendra Manikrao Agade - Director
- Sudesh Panjabrao Rewaskar - Director
- Sunil Marotrao Ghumde - Director
- Sandip Dinakarrao Bavane - Director
- Sachin Korekar - Director
Quintus Life Sciences reported a net profit of ₹8.19 Lakh (net margin 1.9%) and EBITDA of ₹17.14 Lakh (EBITDA margin 4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Quintus Life Sciences is 18% over three years and 25% over five years. In the latest year (FY 2024) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Quintus Life Sciences is 27AAACQ4234B1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Quintus Life Sciences is U74994MH2016PTC280667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quintus Life Sciences was incorporated on 03 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Quintus Life Sciences by revenue are Biofusion Alliance Private Limited, The Doson Chemicals Private Limited, Stan Rel Private Limited, Mecoson Labs Private Limited, Alpic Remedies Limited and 5 more, all in the Pharma industry (Formulations).
Raghavendra Manikrao Agade was appointed as Director on 03 May 2016. Sachin Korekar was appointed as Director on 03 May 2016. Sandip Dinakarrao Bavane was appointed as Director on 03 May 2016. Quintus Life Sciences has 5 board changes on record in total.
Quintus Life Sciences can be reached through the website quintuslifesciences.com. Its registered office is in Jambhulpada, Maharashtra, India.